Table 2.
Baseline and 3-Month Follow-up Sex- and Drug-Risk Behaviors
| Baseline (N = 100) | 3-Month Follow-up (N = 91) | |||||
|---|---|---|---|---|---|---|
|
Outcome Measure n (%)a or M (SD) |
Baseline Total Sample (N = 100) |
Nutrition Condition (n = 49) |
Woman-Focused Intervention Condition (n = 51)b |
Follow-up Total Sample (N = 91) |
Nutrition Condition (n = 42) |
Woman-Focused Intervention Condition (n = 49) |
| Traded sex for drugs, money, clothing, shelter, or any other goods in 90 days prior to drug treatment (yes) | 30 (30%) | 16 (32.7%) | 14 (27.5%) | 38 (41.8%) | 14 (33.3%) | 24 (49.0%) |
| Protected last sex acts with main sex partner (yes)c | 18 (36.7%) | 9 (37.5%) | 9 (36%) | 47 (59.5%)++ | 16 (47.1%) | 31 (68.9%)* |
| Mean number unprotected vaginal sex acts with main sex partner in 30 days prior to entering drug treatmentc | 7.8 (8.8 SD) | 6.4 (7.8 SD) | 9.0 (9.5 SD) | 4.3 (5.8 SD)++ | 6.4 (6.8 SD) | 2.6 (4.2 SD)** |
| Mean number unprotected sex acts with sex trading partner in 30 days prior to entering drug treatment | 4.1 (19.6 SD) | 7.5 (26.6 SD) | 0.2 (0.6 SD) | 2.3 (13.1 SD) | 5.5 (20.6 SD) | 0.1 (0.4 SD) |
| Impaired last sex (yes) | ||||||
| Participant | 87 (89.7%) | 40 (85.1%) | 47 (94.0%) | 68 (78.2%)+ | 30 (75.0%) | 38 (80.9%) |
| Partner | 35 (36.1%) | 15 (31.9%) | 20 (40.0%) | 20 (23.0%) | 12 (30.0%) | 8 (17.0%) |
| Impaired last vaginal sex - Unprotected (yes) | 38 (39.2%) | 18 (38.3%) | 20 (40.0%) | 26 (29.9%) | 12 (30.0%) | 14 (29.8%) |
| Last sex with main sex partner using female condom (yes)c | 0 | 0 | 0 | 8 (12.1%) | 0 | 8 (18.6%)* |
| Mean number of injections in past 30 days prior to drug treatment | 96.7 (40.0 SD) | 99.1 (41.6 SD) | 94.6 (39.0 SD) | 42.0 (40.2 SD) | 44.6 (40.1 SD) | 39.6 (40.6 SD) |
| Mean number of times used cotton, cooker/spoon, or rinse water used by someone else in past 30 days | 8.0 (19.8 SD) | 3.4 (6.8 SD) | 12.0 (24.0 SD) | 0.6 (2.7 SD) | 1.2 (3.9 SD) | 0.1 (0.4 SD) |
| Mean number of times someone else used your cotton, cooker/spoon, or rinse water in past 30 days | 6.0 (17.8 SD) | 3.1 (8.8 SD) | 8.5 (22.7 SD) | 1.2 (2.8 SD) | 1.5 (3.1 SD) | 1.0 (2.7 SD) |
| Mean number of times injected drugs mixed with water from someone else's syringe in the past 30 days (i.e. syringe-mediated drug sharing) | 7.2 (18.3 SD) | 1.7 (4.5 SD) | 12.8 (24.5 SD)* | 0.5 (1.6 SD) | 0.9 (2.2 SD) | 0.1 (0.5 SD)* |
| Mean days injected heroin only |
28.5 (5.8 SD) | 28.1 (6.9 SD) | 28.9 (4.8 SD) | 14.7 (13.0 SD) | 15.4 (13.8 SD) | 14.0 (12.3 SD) |
| Any drugs injected | ||||||
| Cocaine only | 41 (45.6%) | 19 (44.2%) | 22 (46.8%) | 1 (1.1%) | 1 (2.4%) | 0 |
| Heroin and cocaine | 41 (44.1%) | 19 (41.3%) | 22 (46.8%) | 3 (3.3%) | 2 (4.8%) | 1 (2.0%) |
| Any drugs smoked/snorted, | ||||||
| Marijuana | 43 (58.9%) | 19 (55.9%) | 24 (61.5%) | 10 (11.0%) | 4 (9.5%) | 6 (12.2%) |
| Ecstasy only | 43 (53.1%) | 19 (51.4%) | 24 (54.6%) | 8 (8.8%) | 3 (7.1%) | 5 (10.2%) |
| Crack/cocaine only | 41 (46.1%) | 19 (44.2%) | 22 (47.8%) | 4 (4.4%) | 1 (2.4%) | 3 (6.1%) |
| Heroin only | 42 (51.9%) | 19 (48.7%) | 23 (54.8%) | 0 | 0 | 0 |
| Jeff | 19 (24.1%) | 8 (21.1%) | 11 (26.8%) | 2 (2.2%) | 1 (2.4%) | 1 (2.0%) |
a Percentage of participants who responded Yes within the given intervention group, some variable have missing responses due to lack of relevance for individual participants.
b "*" Markings of significance indicate significant group differences between the Nutrition and the Woman-focused intervention groups within time (i.e., baseline or3-month follow-up). "+"Markings of significance indicate significant over time differences either overall, or within the Nutrition or the Woman-focused intervention group.
c Of those that had main sex partners and had intercourse with them.
*p < .05; **p < .01; ***p < .001
+p < .05; ++p < .01; +++p < .001